Dynamic Splinting for Excessive Pronation Following CVA (SupPro Botox)

Dynasplint Systems.

Status: Withdrawn

Conditions: Pronation Contracture

Treatments: Device: Dynasplint

Study type: Interventional

Funder types: Industry

Identifiers

NCT00900692

2009.001

Details and patient eligibility

About

The purpose of this study is to examine range of motion and lasting effects of Botox injections along with the use of the Supination Dynasplint.

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion and exclusion criteria

Inclusion Criteria

Patients enrolled will have been diagnosed with excessive pronation following a stroke and will display the following symptoms:

• Pronation Contracture
• Ability to provide consent and follow directions as related to the protocol

Exclusion Criteria

• Treatment with Benzodiazepines
• Treatment with Baclofen (pump or oral)
• Treatment with Dantrolene sodium
• Treatment with Tizanidine

Trial design

Primary purpose: Treatment

Allocation: Randomized

Interventional model: Single Group Assignment

Masking: None (Open label)

---

0 participants in 2 patient groups

Dynasplint Group

Experimental group

Description:

Along with the standard of care Botox and manual therapy, patients will use the Supination Dynasplint every day

Treatment:

Device: Dynasplint

Standard of care

No Intervention group

Description:

Patients in the standard of care group will have the standard Botox treatments and manual therapy with no additional interventions.